Sickle cell disease: open trials in Colombia

3 open trials have a site in Colombia. Registry data; only the trial team decides who can take part.

NCT06439082
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Cali · Medellín · Montería
Registry updated 2026-10-15
NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Sociedad de Oncología y Hematología del Cesar SAS (SOHEC), Antioquia · Clinica De La Costa, Barranquilla · Fundación Valle del Lili, Cali · Centro de investigaciones clínicas, fudación valle del lili, Cali · Hospital Pablo Tobón Uribe, Medellín · Clínica IMAT Oncomedica Auna S.A.S., Montería · Sociedad de Oncología y Hematología del Cesar SAS (SOHEC), Valledupar
Registry updated 2026-09-17
NCT04657822
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Barranquilla · Cali · Montería · Valledupar
Registry updated 2026-06-08

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)